203 related articles for article (PubMed ID: 25339362)
1. Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation.
Xu H; Wandersee NJ; Guo Y; Jones DW; Holzhauer SL; Hanson MS; Machogu E; Brousseau DC; Hogg N; Densmore JC; Kaul S; Hillery CA; Pritchard KA
Blood; 2014 Dec; 124(26):3978-81. PubMed ID: 25339362
[TBL] [Abstract][Full Text] [Related]
2. The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase.
Vogel S; Arora T; Wang X; Mendelsohn L; Nichols J; Allen D; Shet AS; Combs CA; Quezado ZMN; Thein SL
Blood Adv; 2018 Oct; 2(20):2672-2680. PubMed ID: 30333099
[TBL] [Abstract][Full Text] [Related]
3. TIFA upregulation after hypoxia-reoxygenation is TLR4- and MyD88-dependent and associated with HMGB1 upregulation and release.
Ding N; Zhang Y; Loughran PA; Wang Q; Tsung A; Billiar TR
Free Radic Biol Med; 2013 Oct; 63():361-7. PubMed ID: 23722163
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.
Zhang Y; Karki R; Igwe OJ
Biochem Pharmacol; 2015 Nov; 98(1):132-43. PubMed ID: 26367307
[TBL] [Abstract][Full Text] [Related]
5. High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4.
Bauer EM; Shapiro R; Zheng H; Ahmad F; Ishizawar D; Comhair SA; Erzurum SC; Billiar TR; Bauer PM
Mol Med; 2013 Feb; 18(1):1509-18. PubMed ID: 23269975
[TBL] [Abstract][Full Text] [Related]
6. High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway.
Han L; Zhang M; Wang M; Jia J; Zhao M; Fan Y; Li X
PLoS One; 2016; 11(4):e0154187. PubMed ID: 27100831
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
Sachdev U; Cui X; Tzeng E
J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
[TBL] [Abstract][Full Text] [Related]
8. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
Front Immunol; 2020; 11():613278. PubMed ID: 33542720
[TBL] [Abstract][Full Text] [Related]
9. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
[TBL] [Abstract][Full Text] [Related]
10. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.
Yang H; Hreggvidsdottir HS; Palmblad K; Wang H; Ochani M; Li J; Lu B; Chavan S; Rosas-Ballina M; Al-Abed Y; Akira S; Bierhaus A; Erlandsson-Harris H; Andersson U; Tracey KJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11942-7. PubMed ID: 20547845
[TBL] [Abstract][Full Text] [Related]
11. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice.
Chen L; Li J; Ye Z; Sun B; Wang L; Chen Y; Han J; Yu M; Wang Y; Zhou Q; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():585094. PubMed ID: 33193406
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 takes a "Toll" in sickle cell disease.
Gupta K
Blood; 2014 Dec; 124(26):3837-8. PubMed ID: 25525080
[No Abstract] [Full Text] [Related]
13. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
14. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.
Kim S; Kim SY; Pribis JP; Lotze M; Mollen KP; Shapiro R; Loughran P; Scott MJ; Billiar TR
Mol Med; 2013 May; 19(1):88-98. PubMed ID: 23508573
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.
Mcdonald KA; Huang H; Tohme S; Loughran P; Ferrero K; Billiar T; Tsung A
Mol Med; 2015 Mar; 20(1):639-48. PubMed ID: 25375408
[TBL] [Abstract][Full Text] [Related]
16. miR-708 affords protective efficacy in anoxia/reoxygenation-stimulated cardiomyocytes by blocking the TLR4 signaling via targeting HMGB1.
Zhang S; Wang Y; Wang P; Xuan J
Mol Cell Probes; 2020 Dec; 54():101653. PubMed ID: 32866662
[TBL] [Abstract][Full Text] [Related]
17. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
18. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 cessation antagonizes hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and inflammation via the HMGB1-TLR4 axis.
Zhang Y; Zhang H; Zhang Z; Li S; Jiang W; Li X; Lv J
Mol Immunol; 2019 Aug; 112():22-29. PubMed ID: 31075559
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 was negatively regulated by HSF1 and mediated the TLR4/MyD88/NF-κB signal pathway in asthma.
Shang L; Wang L; Shi X; Wang N; Zhao L; Wang J; Liu C
Life Sci; 2020 Jan; 241():117120. PubMed ID: 31825792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
